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1. Introduction 
A basic trypsin inhibitor (Kunitz inhibitor) has 
been isolated from bovine pancreas [1-4] ,  lungs [5], 
parotid glands [6], liver [7], and this polypeptide has 
been thought o be present in several other tissues of 
the ox [8]. This paper describes the isolation of Kunitz 
inhibitor from ovary by affinity chromatography and 
its characterization by amino acid analysis and partial 
sequence determination. 
2. Results 
2.1. Purif~ation o f  ovary inhibitor 
Inhibitor has first been purified by Sachet al. [9] 
under conditions previously described for pancreatic 
trypsin inhibitor. However, the purified material 
(Batch 10.099 RB: Choay) showed several components 
by paper electrophoresis [10] so that further purifica- 
tion was necessary. Because affinity chromatography 
of trypsins on ovomucoid-Sepharose wassuccessful 
[11], a chromatography of ovary inhibitor on trypsin- 
Sepharose was attempted. Such a procedure has 
previously been used by Kassel and Marciniszyn [12] 
for isolation of pancreatic nhibitor. Activation of 
Sepharose was performed according to Cuatrecasas etal. 
[13] : 15 ml of Sepharose 4 B (Pharmacia) are filtered 
on a sintered glass, washed with water and resuspended 
in 40 ml of water; cyanogen bromide (2 g dissolved in 
3 ml of water) is added. The pH is immediately 
adjusted to 11 by titration with 5 N NaOH and main. 
tained for 10 min. After filtration on a sintered glass ~ 
funnel, the activated Sepharose is rapidly washed with 
about 1 1 of cold water and then with the same volume 
of cold 0.05 M sodium borate buffer pH 9. The 
activated Sepharose is suspended in 20 ml of borate 
buffer and 300 mg of pig trypsin (Batch CB 526: 
Choay), dissolved in 5 ml of the same buffer con- 
taining 0.01 M CaCI~, are quickly added; the mixture 
is gently stirred at 4 ° for 18 hr. Trypsin-Sepharose 
is then washed with 1 1 of 0.05 M borate buffer pH 9 
containing 0.3 M NaC1 and 0.01 M CaC12. A column 
of 1.5 × 7.5 cm is set up and equilibrated with 0.1 M 
acetate buffer pH 4.0 containing 0.3 M NaC1 and 
0.01 M CaC12. After about 400 ml, the absorbance at
280 nm is negligible and trypsin-Sepharose i  ready 
for use. 
18 mg of partially purified ovary inhibitor dissolved 
in 2 ml of acetate buffer pH 4.0, are placed on the 
column; trypsin-Sepharose i  washed with the same 
buffer, and 3 ml fractions are collected. After 75 ml, 
no inhibitory activity was detected but an inactive 
material is found in the effluent (fig. 1); this product 
is desalted by gel-filtration on Sephadex G-25 with 
0.1 M acetic acid and freeze-dried (2.3 mg). Inhibitor 
is eluted 0.1 M HC1 containing 0.5 M NaC1 and 0.01 M 
CaClz (pH 1.2). After about 30 ml, inhibitor appears 
in the effluent; active fractions are pooled (24 ml), 
dialysed against water (3 changes of 100 ml, 30 min 
each) and desalted by passage through a column 
(0.9 × 61 cm) of Sephadex G-10 using 0.1 M acetic 
acid. The lyophilized material weighs 8.8 mg. 
2.2. Characterization of  ovary inhibitor 
The amino acid composition of ovary inhibitor has 
been determined according to Spackman et al. [ 14]. 
Samples of 50-60 nmoles of polypeptide were 
hydrolyzed in an evacuated, sealed tube with 6 N HC1 
for 48 hr at 110 °. Amino acid analysis was performed 
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Fig. 1. Affinity chromatography of ovary trypsin inhibitor on 
trypsin-Sepharose (d tails in the text). 
on an automatic analyzer Spinco 120 B fitted with a 
high-sensitivity cell. Cystine and methionine contents 
were determined as cysteic acid and methionine 
sulfone, respectively, on oxidized samples. Table 1 
shows the experimental results for ovary inhibitor and 
the amino acid composition found for pancreatic 
trypsin inhibitor. It is clear that the two products 
have identical amino acid compositions. 
Comparison between pancreatic and ovary inhibitors 
has been achieved by analysis of the peptides obtained 
by trypsin hydrolysis of performic acid oxidized 
products. Digestion by trypsin and isolation of tryptic 
fragments by peptide mapping were carried out as 
previously described [15]. The same 9 tryptic peptides 
found for pancreatic inhibitor were detected. Tryptic 
peptides were analyzed and results are given in table 2. 
Homologous peptides from both inhibitors have 
identical amino acid compositions. On the other hand 
peptides T3, T 4 and T s were subjected to Edman 
degradation by using the paper strip variant [16, 17]. 
About 250 nmoles of  each were employed. Tile 
sequences of the first residues (2, 5 and 3, respectively) 
were those expected. 
Automatic Edman degradation [17] has been per- 
formed On inhibitor with a SOCOSI sequencer Model 
PS 100. Either native or carboxamidomethylated 
inhibitors were used. Carboxamidomethytated d ri- 
vative (CAM-inhibitor) was prepared by reducing 
inhibitor (25 mg dissolved in 4 ml of  0.1 M borate 
Table 1 
Comparison of amino acid compositions of trypsin inhibitors 
from bovine pancreas and~ovary (molar atio, using leucine as 
reference). 
Amino acid 
Inhibitor Inhibitor from ovary 
from 
pancreas Performic 
(number of Non-oxidized acid 
residues (65 nmoles) oxidized 
per mole) (48 nmoles) 
Lys 4 3.72 3.60 
Arg 6 6.10 6.05 
Asp 5 5.15 5.09 
Thr 3 2.42 2.61 
Ser 1 1.03 0.96 
Glu 3 3.03 3.17 
Pro 4 3.52 4.00 
Gly 6 6.12 6.17 
Ala 6 6.24 6.22 
Cys* 6 5.67 6.60 
Val 1 0.97 1.13 
Met* 1 0.76 1.05 
lie 2 1.45 1.61 
Leu 2 2.00 2.00 
Tyr 4 3.73 3.04 
Phe 4 4.03 4.13 
* Determined as cysteic acid and methionine sulfone, 
respectively, in the performic acid oxidized sample. 
buffer pH 8.1 containing 8 M urea) with dithiothreitol 
(10 mg in 0.1 ml of buffer). After 18 hr at room temp., 
iodoacetamide (20 mg) is added and the pH is main- 
tained at 8.1 for 15 min with 0.1 M NaOH. The pH is 
lowered to 3.0 with 0.1 M acetic acid. Urea and salts 
are removed by passage through a column of Sephadex 
G-25 equilibrated with 0.1 M acetic acid and CAM- 
inhibitor is lyophilized (21 mg). 
Merck reagents (Kit 8012 for sequential analysis) 
were used for Edman degradation. The program is 
virtually identical to that described by Edman and 
Begg [18]. About 600 nmoles were used either for 
native inhibitor or for CAM-inhibitor. Phenythio- 
hydantoins of amino acids were identified by thin- 
layer chromatography [19]. Except for steps 1 and 17 
where arginine derivative, non-extracted by chloro- 
butane, could not be identified, the amino acids 
expected for Kunitz inhibitor were found until iso- 
leucine no. 18 after which no phenylthiodantoin was 
obtained. It is of interest o note that Edman degrada- 
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tion is not stopped by the half cystine no. 5 in native 
inhibitor although this residue is bound in a 5 -55  
disulfide bridge. Similar observation was~made with 
the half-cystine no. 1 of neurohypophysial hormones 
[201. 
3. Discussion 
Ovary inhibitor has the same amino acid composi- 
tion as pancreatic inhibitor (Kunitz) gives the same 
tryptic peptides and has a similar N-terminal sequence. 
It can be concluded that both inhibitors are identical. 
Kunitz inhibitor has so far been chemically identified 
in five organs, namely pancreas, lungs, parotid glands, 
liver and ovary, and is likely present in most tissues. 
However its physiological function is not clear. It 
could play a general role in intracellular metabolism. 
If the function is really to inhibit a trypsin-like 
enzyme, its presence could indicate that of a trypsin- 
like protease. Up to now Kunitz inhibitor has only 
been found in ox and sheep [21] and its distribution 
in mammals or other vertebrates remains to be in- 
vestigated. 
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